These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 34357802)

  • 1. Memantine Promotes Bactericidal Effect of Neutrophils Against Infection with
    Xiao Y; Zhang TS; Li YH; Liu CF; Yang SJ; Zeng LT; Huang SH; Deng XY; Peng L
    Microb Drug Resist; 2022 Jan; 28(1):7-17. PubMed ID: 34357802
    [No Abstract]   [Full Text] [Related]  

  • 2. Memantine Displays Antimicrobial Activity by Enhancing
    Peng L; Li L; He XL; Yu JY; Zeng ZJ; Yang WJ; Zhang B; Zhang TS; Cao H; Huang SH; Liu LQ
    Front Cell Infect Microbiol; 2020; 10():47. PubMed ID: 32117815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of in vitro critical inhibitory concentration, a novel approach to predict in vivo synergistic bactericidal effect of combined amikacin and piperacillin against Pseudomonas aeruginosa in a systemic rat infection model.
    Chan E; Zhou S; Srikumar S; Duan W
    Pharm Res; 2006 Apr; 23(4):729-41. PubMed ID: 16554956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amikacin and cefoperazone/sulbactam alone or in combination against carbapenem-resistant Pseudomonas aeruginosa.
    Cai Y; Yang D; Wang J; Wang R
    Diagn Microbiol Infect Dis; 2018 Jun; 91(2):186-190. PubMed ID: 29486972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipseudomonal agents exhibit differential pharmacodynamic interactions with human polymorphonuclear leukocytes against established biofilms of Pseudomonas aeruginosa.
    Chatzimoschou A; Simitsopoulou M; Antachopoulos C; Walsh TJ; Roilides E
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2198-205. PubMed ID: 25645829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
    Dambrauskiene A; Adukauskiene D; Jeroch J; Vitkauskiene A
    Medicina (Kaunas); 2009; 45(1):1-7. PubMed ID: 19223699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates.
    Montero MM; Domene Ochoa S; López-Causapé C; Luque S; Sorlí L; Campillo N; López Montesinos I; Padilla E; Prim N; Angulo-Brunet A; Grau S; Oliver A; Horcajada JP
    Microbiol Spectr; 2021 Sep; 9(1):e0058521. PubMed ID: 34319141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with the Pseudomonas aeruginosa Glycoside Hydrolase PslG Combats Wound Infection by Improving Antibiotic Efficacy and Host Innate Immune Activity.
    Pestrak MJ; Baker P; Dellos-Nolan S; Hill PJ; Passos da Silva D; Silver H; Lacdao I; Raju D; Parsek MR; Wozniak DJ; Howell PL
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30988141
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative in vitro bactericidal activity between cefepime and ceftazidime, alone and associated with amikacin, against carbapenem-resistant Pseudomonas aeruginosa strains.
    Bantar C; Di Chiara M; Nicola F; Relloso S; Smayevsky J
    Diagn Microbiol Infect Dis; 2000 May; 37(1):41-4. PubMed ID: 10794939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of Amikacin Hyper-Resistant Pseudomonas aeruginosa After Stepwise Exposure to High Amikacin Concentrations.
    Amábile-Cuevas CF
    Microb Drug Resist; 2017 Jan; 23(1):32-36. PubMed ID: 27183474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activities of ceftobiprole combined with amikacin or levofloxacin against Pseudomonas aeruginosa: evidence of a synergistic effect using time-kill methodology.
    Kresken M; Körber-Irrgang B; Läuffer J; Decker-Burgard S; Davies T
    Int J Antimicrob Agents; 2011 Jul; 38(1):70-5. PubMed ID: 21514795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
    Petit JC; Richard G; Burghoffer B; Daguet GL
    Pathol Biol (Paris); 1982 Jun; 30(6):426-31. PubMed ID: 6810286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single β-lactams versus combinations as empiric therapy for infections with
    Almarzoky Abuhussain SS; Sutherland CA; Nicolau DP
    Infect Dis (Lond); 2020 Jan; 52(1):33-38. PubMed ID: 31595829
    [No Abstract]   [Full Text] [Related]  

  • 14. Pseudomonas aeruginosa Quorum Sensing Molecule Alters Skeletal Muscle Protein Homeostasis by Perturbing the Antioxidant Defense System.
    Bandyopadhaya A; Tzika AA; Rahme LG
    mBio; 2019 Oct; 10(5):. PubMed ID: 31575771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo synergy of levofloxacin or amikacin both in combination with ceftazidime against clinical isolates of Pseudomonas aeruginosa.
    Piccoli L; Guerrini M; Felici A; Marchetti F
    J Chemother; 2005 Aug; 17(4):355-60. PubMed ID: 16167512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bactericidal efficacy of cold atmospheric plasma treatment against multidrug-resistant
    Wang L; Xia C; Guo Y; Yang C; Cheng C; Zhao J; Yang X; Cao Z
    Future Microbiol; 2020 Jan; 15():115-125. PubMed ID: 31989838
    [No Abstract]   [Full Text] [Related]  

  • 17. Pseudomonas aeruginosa Effector ExoS Inhibits ROS Production in Human Neutrophils.
    Vareechon C; Zmina SE; Karmakar M; Pearlman E; Rietsch A
    Cell Host Microbe; 2017 May; 21(5):611-618.e5. PubMed ID: 28494242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial activity of liposomal amikacin against Pseudomonas aeruginosa in vitro.
    Antos M; Trafny EA; Grzybowski J
    Pharmacol Res; 1995; 32(1-2):85-7. PubMed ID: 8668652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PrtR homeostasis contributes to Pseudomonas aeruginosa pathogenesis and resistance against ciprofloxacin.
    Sun Z; Shi J; Liu C; Jin Y; Li K; Chen R; Jin S; Wu W
    Infect Immun; 2014 Apr; 82(4):1638-47. PubMed ID: 24491574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum beta-lactamase-producing strain of Pseudomonas aeruginosa.
    Mimoz O; Elhelali N; Léotard S; Jacolot A; Laurent F; Samii K; Petitjean O; Nordmann P
    J Antimicrob Chemother; 1999 Jul; 44(1):91-7. PubMed ID: 10459815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.